Prognostic role of the combination of platelet count and neutrophil-lymphocyte ratio in patients with hypopharyngeal squamous cell carcinoma

scientific article

Prognostic role of the combination of platelet count and neutrophil-lymphocyte ratio in patients with hypopharyngeal squamous cell carcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00405-016-3996-3
P698PubMed publication ID27020267

P2093author name stringTakahiro Hayashi
Masashi Sugasawa
Satoko Matsumura
Mitsuhiko Nakahira
Yasuhiro Ebihara
Yasunao Kogashiwa
Kazuhiko Minami
Kiyomi Kuba
Susumu Ohba
P2860cites workHuman papillomavirus and survival of patients with oropharyngeal cancer.Q27851567
Effects of cancer on plateletsQ33416410
Cancer and inflammation: promise for biologic therapy.Q34139732
Lower circulating platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinomaQ34306349
Platelets and cancer: implications for antiangiogenic therapyQ34555485
A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.Q36166771
Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysisQ36839249
Circulating IL-6 concentrations link tumour necrosis and systemic and local inflammatory responses in patients undergoing resection for colorectal cancerQ37003359
Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancerQ37040591
Prognostic biomarkers of survival in oropharyngeal squamous cell carcinoma: systematic review and meta-analysis.Q38045266
The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancerQ38100418
Preoperative neutrophil-to-lymphocyte ratio as prognostic predictor for hypopharyngeal squamous cell carcinoma after radical resectionsQ38341077
HPV: a factor in organ preservation for locally advanced larynx and hypopharynx cancer?Q42263015
Presence of human papillomaviruses and p16 expression in hypopharyngeal cancerQ44817366
Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER databaseQ44849577
Thrombocytosis associated with poor prognosis in patients with esophageal carcinomaQ44864148
Poor prognosis associated with thrombocytosis in patients with gastric cancerQ45164824
Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients undergoing surgery for gastric cancerQ45893288
Thrombocytosis in patients with tumors producing colony-stimulating factorQ67899702
[Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]Q70507813
Evidence-based management of hypopharyngeal cancerQ78383079
Interleukin-6 predicts recurrence and survival among head and neck cancer patientsQ81413488
P433issue11
P921main subjectlymphocyteQ715347
hypopharyngeal squamous cell carcinomaQ53678413
P1104number of pages5
P304page(s)3863-3867
P577publication date2016-03-28
P1433published inEuropean Archives of Oto-Rhino-LaryngologyQ2624005
P1476titlePrognostic role of the combination of platelet count and neutrophil-lymphocyte ratio in patients with hypopharyngeal squamous cell carcinoma
P478volume273

Reverse relations

cites work (P2860)
Q37558436Cancer and Thrombosis: The Platelet Perspective.
Q90828149High pretreatment neutrophil-to-lymphocyte ratio as a predictor of poor survival prognosis in head and neck squamous cell carcinoma: Systematic review and meta-analysis
Q37702050Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan.
Q52918719Lymph Node Ratio Predicts Recurrence and Survival for Patients with Resectable Stage 4 Hypopharyngeal Cancer.
Q48133074Modified combination of platelet count and neutrophil "to" lymphocyte ratio as a prognostic factor in patients with advanced head and neck cancer.
Q88674554Neutrophil-to-lymphocyte ratio as a prognostic indicator in head and neck cancer: A systematic review and meta-analysis
Q48197231Neutrophil-to-lymphocyte ratio in head and neck cancer prognosis: A systematic review and meta-analysis
Q92510776Novel prognostic clinical factors and biomarkers for outcome prediction in head and neck cancer: a systematic review
Q90917816Platelet count and platelet-lymphocyte ratio as prognostic markers for head and neck squamous cell carcinoma: Meta-analysis
Q33758269Pretreatment combination of platelet counts and neutrophil-lymphocyte ratio predicts survival of nasopharyngeal cancer patients receiving intensity-modulated radiotherapy
Q55279094Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.
Q48117100Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis
Q90521213Sex Differences in Using Systemic Inflammatory Markers to Prognosticate Patients with Head and Neck Squamous Cell Carcinoma
Q54701705The Pretreatment Neutrophil-to-Lymphocyte Ratio is a Prognostic Determinant of T3-4 Hypopharyngeal Squamous Cell Carcinoma.
Q60920889The Prognostic Significance of Neutrophil-to-Lymphocyte Ratio in Head and Neck Cancer Patients Treated with Radiotherapy
Q47150674The combination of preoperative platelet count and neutrophil lymphocyte ratio as a prognostic indicator in localized renal cell carcinoma

Search more.